BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10574632)

  • 1. Enhanced IL-10 production in vitro by monocytes in autoimmune haemolytic anaemia.
    Fagiolo E; Terenzi CT
    Immunol Invest; 1999; 28(5-6):347-52. PubMed ID: 10574632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
    Fagiolo E; Abenante L
    Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia.
    Ahmad E; Elgohary T; Ibrahim H
    J Investig Allergol Clin Immunol; 2011; 21(4):297-304. PubMed ID: 21721376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1 and Th2 cytokine modulation by IL-10/IL-12 imbalance in autoimmune haemolytic anaemia (AIHA).
    Fagiolo E; Toriani-Terenzi C
    Autoimmunity; 2002 Feb; 35(1):39-44. PubMed ID: 11908705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation.
    Barcellini W; Clerici G; Montesano R; Taioli E; Morelati F; Rebulla P; Zanella A
    Br J Haematol; 2000 Nov; 111(2):452-60. PubMed ID: 11122084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of blood mononuclear cells from human donors with autoimmune haemolytic anaemia to reconstitute severe combined immunodeficient mice.
    Macht LM; Leader KA; Corrall RJ; Yates P; Elson CJ
    Autoimmunity; 1992; 14(2):127-35. PubMed ID: 1303679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus.
    Lang B; Straub RH; Weber S; Röther E; Fleck M; Peter HH
    Lupus; 1997; 6(8):652-5. PubMed ID: 9364424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine network in autoimmune haemolytic anaemia: new probable targets for therapy.
    Toriani-Terenzi C; Pozzetto U; Bianchi M; Fagiolo E
    Cancer Detect Prev; 2002; 26(4):292-8. PubMed ID: 12430633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin antibodies, haemolytic anaemia and thrombocytopenia in systemic lupus erythematosus.
    Fong KY; Loizou S; Boey ML; Walport MJ
    Br J Rheumatol; 1992 Jul; 31(7):453-5. PubMed ID: 1628167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 response abnormalities in systemic lupus erythematosus.
    Mongan AE; Ramdahin S; Warrington RJ
    Scand J Immunol; 1997 Oct; 46(4):406-12. PubMed ID: 9350293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE.
    Andersen LS; Petersen J; Svenson M; Bendtzen K
    Autoimmunity; 1999; 30(4):235-42. PubMed ID: 10524499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 is expressed at normal levels in patients with autoimmune haemolytic anaemia and/or immune thrombocytopenia.
    Ahrens N; Pagenkopf C; Kiesewetter H; Salama A
    Transfus Med; 2006 Dec; 16(6):397-402. PubMed ID: 17163870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.
    Neely J; von Scheven E
    Curr Opin Rheumatol; 2018 Sep; 30(5):498-505. PubMed ID: 29979258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5
    Zhao M; Duan N; Wang Y; Zhu H; Liu H; Wang H; Xing L; Shao Z
    Autoimmunity; 2019 Feb; 52(1):12-20. PubMed ID: 30784322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
    Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
    Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia.
    Toriani-Terenzi C; Fagiolo E
    Ann N Y Acad Sci; 2005 Jun; 1051():29-44. PubMed ID: 16126942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical complement activation on human erythrocytes in subjects with systemic lupus erythematosus and a history of autoimmune hemolytic anemia.
    Hair P; Goldman DW; Li J; Petri M; Krishna N; Cunnion K
    Lupus; 2020 Sep; 29(10):1179-1188. PubMed ID: 32659155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M; Silverman ED; Levy DM
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.
    Xie J; Cui D; Liu Y; Jin J; Tong H; Wang L; Ruan G; Lu Y; Yuan H
    Int J Biol Sci; 2015; 11(2):220-9. PubMed ID: 25561904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.